The MSP domain is an evolutionarily conserved immunoglobulin-like structure of about 120 amino acids. A P56S mutation in the MSP domain of the human vapB gene causes a dominantly inherited form of Amyotropic Lateral Sclerosis (ALS) or sometimes Spinal Muscular Atrophy (SMA) (Nishimura et al., 2004). In C. elegans, MSP is the most abundant protein in sperm and is the founding member of MSP domain family. MSP functions as an intracellular cytoskeleton protein and a secreted hormone. Secreted MSP binds to the VAB-1 Eph receptor and other receptors on oocyte and ovarian sheath cell surfaces to induce oocyte maturation and sheath contraction. We have recently shown that worm, fly, and human VAPB MSP domains are secreted ligands for Eph receptors and other receptors. The human VAPB MSP domain is found in blood serum, consistent with a hormonal function. In fly cells, the P56S mutation prevents secretion of the VAPB MSP domain, suggesting that the signaling function is important for ALS and SMA pathogenesis (Tsuda et al., 2008). To better understand how MSP domains transduce signals, I have been studying the PTP-2 tyrosine phosphatase, an SHP homolog that is thought to couple receptor tyrosine kinase (RTK) activation to the MAPK cascade. Previous studies have shown that MSP promotes MPK-1 MAPK phosphorylation during oocyte maturation (Miller et al., 2001) and that PTP-2 is required for normal fertility (Gutch et al., 1998). I have shown that PTP-2 is expressed in the gonad, where it is required for MSP-induced oocyte maturation and MAPK activation, but not MSP-induced sheath contraction. Expressing GFP::PTP-2 specifically in the germ line can partially rescue the oocyte maturation defects, embryonic lethality, and larval lethality of
ptp-2 null mutants. Furthermore, these
ptp-2 null defects can be rescued by inactivating multiple RAS GAPs, as well as by a RAS gain of function mutation. MSP binding studies show that MSP receptors are present on the oocyte and sheath plasma membranes in
ptp-2 null mutants. These results are consistent with a model in which MSP regulates the activity of a canonical RTK/MAPK pathway to induce oocyte maturation. The identity of the RTK is not known and it is not clear whether MSP regulates RTK activation through a direct interaction (i.e. the RTK is an MSP receptor) or indirectly. VAPB homologs may also regulate the MAPK pathway because PTP-2 is expressed in muscle and loss of PTP-2 causes muscle mitochondrial defects that are similar to loss of worm VAPB (called VPR-1).